Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non Interventional Observational Study to Collect Data for the Effect of Switching to Neupro® on Severity of Restless Leg Syndrome (RLS) Symptoms and Augmentation as Well as the Change in Treatment Regimen Used, in RLS Patients With Previous Augmentation

NCT01386944 is registered in ClinicalTrials.gov with UCB Pharma as lead sponsor.

NCT NCT01386944
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01386944 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non Interventional Observational Study to Collect Data for the Effect of Switching to Neupro® on Severity of Restless Leg Syndrome (RLS) Symptoms and Augmentation as Well as the Change in Treatment Regimen Used, in RLS Patients With Previous Augmentation
Lead sponsor
UCB Pharma
Phase
Observational
Overall status
Completed
Start date
July 31, 2011
Completion date
August 31, 2013
Enrollment
102 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

restless legs syndrome